Collegium Pharmaceutical, Inc. COLL Symproic and other — Total amortization expense

Other product segments

Similar metrics at other companies

NCNOProfessional services and other — Total amortization expense

$0-100%

MNKDAll Other Segments — Intangible Amortization

$4.37M+340%

BWINCorporate Segment and Other Operating Segment — Depreciation and amortization expense

$1.71M+21.8%

EPACOther Operating Segment — Intangible Amortization

$0—

ALRMOther — Amortization and depreciation

$1.68M+468%

PANWProduct — Total intangible assets amortization

$37M—

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s symproic and other — total amortization expense?

Collegium Pharmaceutical, Inc. (COLL) reported symproic and other — total amortization expense of $1.82M in Q4 2025.

How has Collegium Pharmaceutical, Inc.'s symproic and other — total amortization expense changed year-over-year?

Collegium Pharmaceutical, Inc.'s symproic and other — total amortization expense decreased by 0.0% year-over-year, from $1.82M to $1.82M.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s symproic and other — total amortization expense?

Over 2 years (2023 to 2025), Collegium Pharmaceutical, Inc.'s symproic and other — total amortization expense has grown at a 0.0% compound annual growth rate (CAGR), from $7.29M to $7.29M.

What does symproic and other — total amortization expense mean?

The periodic non-cash expense allocated to the Symproic segment to reflect the systematic reduction in the value of finite-lived intangible assets. This metric is essential for understanding the impact of acquisition-related costs on the segment's reported operating profitability.